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Abstract
Staphylococcus aureus is a prominent human pathogen and leading cause of bacterial infection in hospitals and the
community. Community-associated methicillin-resistant S. aureus (CA-MRSA) strains such as USA300 are highly virulent and,
unlike hospital strains, often cause disease in otherwise healthy individuals. The enhanced virulence of CA-MRSA is based in
part on increased ability to produce high levels of secreted molecules that facilitate evasion of the innate immune response.
Although progress has been made, the factors that contribute to CA-MRSA virulence are incompletely defined. We analyzed
the cell surface proteome (surfome) of USA300 strain LAC to better understand extracellular factors that contribute to the
enhanced virulence phenotype. A total of 113 identified proteins were associated with the surface of USA300 during the late-
exponential phase of growth in vitro. Protein A was the most abundant surfacemolecule of USA300, as indicated by combined
Mascot score following analysis of peptides by tandem mass spectrometry. Unexpectedly, we identified a previously
uncharacterized two-component leukotoxin–herein named LukS-H and LukF-G (LukGH)-as two of the most abundant surface-
associated proteins of USA300. Rabbit antibody specific for LukG indicated it was also freely secreted by USA300 into culture
media.We used wild-typeand isogenic lukGHdeletionstrains of USA300in combination with human PMNpore formationand
lysis assays to identify this molecule as a leukotoxin. Moreover, LukGH synergized with PVL to enhance lysis of human PMNs in
vitro, and contributed to lysis of PMNs after phagocytosis. We conclude LukGH is a novel two-component leukotoxin with
cytolytic activity toward neutrophils, and thus potentially contributes to S. aureus virulence.
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Introduction
Staphylococcus aureus is a leading cause of human bacterial
infections worldwide. The organism can cause a wide range of
diseases, including superficial skin and soft tissue infections, as well
as invasive diseases such as pneumonia, bacteremia, endocarditis,
and joint infections (reviewed in [1]). The high prevalence of
infections is confounded by the ability of the pathogen to readily
acquire genetic elements that confer resistance to antibiotics.
Although methicillin-resistant S. aureus (MRSA) remains a
significant problem for healthcare facilities in most industrialized
countries, an MRSA strain known as USA300 is the most
abundant cause of bacterial infections outside of healthcare
facilities in the United States [2–4]. The ability of USA300 to
cause infections in otherwise healthy individuals suggests the strain
has enhanced capacity to circumvent killing by the innate immune
system—a notion confirmed by studies with human neutrophils
[5]. The ability of CA-MRSA strains such as USA300 to produce
relatively high levels of secreted molecules such as phenol-soluble
modulins (PSMs) provides an explanation in part for the enhanced
ability of these pathogens to avoid destruction by neutrophils [6,7].
Despite this recent progress, our understanding of CA-MRSA
virulence mechanisms is incomplete, largely because S. aureus
produces many molecules that can potentially contribute to
immune evasion and virulence [8]. To gain a comprehensive
view of the molecules that potentially promote USA300 virulence,
we evaluated the surface proteome of this pathogen. Unexpect-
edly, we identified an uncharacterized two-component leukotox-
in—herein named LukS-H and LukF-G—bound to the surface of
USA300, and used USA300 wild-type and isogenic lukGH mutant
strains to verify its ability to function as a leukotoxin.
Results and Discussion
Isolation of peptides from USA300 surface proteins
We optimized the approach described by Rodriguez-Ortega et
al. to determine the cell surface proteome (surfome) of USA300/
LAC [9]. Because S. aureus cell wall-associated proteins are
expressed maximally during exponential growth [10], we used
cultures grown to late-exponential phase of growth. USA300
surface proteins were removed by digestion with trypsin in the
presence of sucrose and DTT, which make surface proteins more
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proteolytic digestion of the bacterial surface proteins has the
potential to cause cell lysis, either through destabilization of the
membrane as a result of loss of membrane proteins or through
activation of bacterial autolytic and/or proteolytic proteins. To
determine if trypsin decreased viability of LAC, we plated the
bacteria before and after digestion with trypsin (F. S1A). There
was a slight increase in CFU/ml after exposure to trypsin; this
phenomenon was likely due to decreased clumping of bacteria
following removal of the proteinaceous surface clumping factors
(Fig. S1A). Although exposure of bacteria to trypsin for an
extended period of time (21 h) resulted in lysis of bacteria (data not
shown), there was no decrease in bacterial viability following the
relatively short trypsin incubation period used here to remove
surface proteins (Fig. S1A). Separation of a representative 1-h
tryptic digest by Tricine SDS-PAGE demonstrated that the surface
proteins were digested into small peptides (Fig. S1B).
Identification of USA300 surface proteins
Peptides recovered from the surface of USA300 were subjected
to fractionation and tandem mass spectrometry (LC-MS/MS) as
outlined in Fig. 1. Using this approach, we identified 113 proteins
associated with the surface of USA300 during late–exponential
phase of growth (Fig. 2, and Tables S1 and S2). Of these proteins,
17 are predicted to be associated with the cell wall using a
combination of PSORT [11] and previous studies (Table S1). In
addition to the 17 cell wall-associated proteins, we recovered 19
extracellular and 14 membrane proteins from the surface protein
preparations of USA300. Three of the 19 putative extracellular
proteins (LukS-H, IsaA, and LukF-G) were also found in high
abundance on the cell surface during exponential or stationary
phase of growth ([12]; this study). As shown in Fig. 2A, 54% of the
peptides (‘‘queries’’ in Table S2) identified by our MS/MS analysis
could be assigned to only 50 proteins (17 cell wall-associated, 19
extracellular, and 14 membrane); the number of peptides assigned
to a protein is a direct measure of the abundance of that protein in
the sample. In contrast, Mascot assigned the remaining 46% of the
identified peptides to 63 proteins that normally reside in the cell
cytoplasm (Table S1 and Fig. 2A). As such, the confidence with
which these proteins were identified was significantly lower than
that for cell wall-associated and/or extracellular proteins (Fig. 2B).
Cell wall-associated proteins
The classical Gram-positive peptide, LPxTG, which covalently
anchors proteins in the cell wall peptidoglycan, is present in 12 of
the 17 cell wall-associated proteins identified by our analysis
(Table S1). The LysM domain, which non-covalently links
proteins to the cell surface, is present in 2 of these 17 proteins,
as well as one membrane protein (EbpS). The most abundant
protein on the surface of USA300 was immunoglobulin G binding
protein A (protein A or Spa), based upon the number of unique
peptides identified (46), the number of total peptides matched
(273), and the combined Mascot score (6910) (Tables S1 and S2).
This finding is in agreement with previously published studies of S.
aureus surface proteins [13–16]. Interestingly, two previously
unidentified/uncharacterized proteins encoded by open reading
frames annotated in the FPR3757 genome as SAUSA300_1975
and SAUSA300_1974 were the 2
nd and 7
th most abundant proteins
on the surface of USA300 (Table S1). SAUSA300_1974 and
SAUSA300_1975 are predicted to encode LukF and LukS subunits
of a two-component leukotoxin, which is present and highly
conserved among all sequenced S. aureus strains (Fig. S2A and
S2B). Here we designate SAUSA300_1974 as lukF-G (or lukG) and
SAUSA300_1975 as lukS-H (or lukH), and the two-gene operon as
lukGH. Neither LukF-G nor LukS-H (hereafter called LukG and
LukH, respectively) contains LPxTG or LysM cell wall anchoring
domains, though both were highly abundant on the surface of S.
aureus during late-exponential growth in vitro (Table S1). We
verified by immunoblot analysis of subcellular fractions of USA300
that LukG is associated with the detergent-soluble membrane
fraction (Fig. 3A).
The majority of the cell wall-associated proteins identified by
our analysis have been described previously (reviewed in [17]).
Interestingly, iron-regulated surface determinants A (IsdA) and B
(IsdB) were the 6
th and 21
st most abundant proteins on the cell
surface, as predicted by Mascot score (Table S1). Expression of the
Isd proteins has been shown to occur only in iron-limited
conditions [18], unlike the rich TSB medium in which USA300
was cultured for this study.
Extracellular/secreted proteins
The methodology we employed to remove proteins from the
surface of USA300 was not specific to conventionally defined
surface proteins (i.e., cell wall-associated and membrane proteins).
Thus, we identified proteins in the process of being secreted into
the culture medium as well. Five of the 10 most abundant proteins
are putative or proven secreted proteins, and 3 others are
associated with both the cell wall and the extracellular milieu.
LukG and LukH are among the most abundant extracellular
Figure 1. Workflow diagram for surface proteomics.
doi:10.1371/journal.pone.0011634.g001
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st and
3
rd in abundance by Mascot score) (Table S1). Gamma-hemolysin
subunit A (HlgA) was the only other two-component leukotoxin
subunit identified as associated with the cell surface (Table S1).
Expression of delta-hemolysin and other secreted proteins, many
of which were identified here, is largely dependent on upregulation
of the global gene regulator agr, which occurs in vitro at the
transition from exponential to stationary phase of growth [10].
Thus, our finding that delta-hemolysin is associated with the
surface of S. aureus suggests bacteria were beginning to make the
transition from exponential growth (high production of cell wall-
associated proteins) to stationary phase of growth (production of
secreted proteins).
Membrane proteins
We identified 14 membrane proteins on the surface of S. aureus
in our surfome analysis. Membrane topology analysis using
HMMTOP showed that many of the peptides assigned to
membrane proteins were located on the exterior of the cell
membrane (Fig. 3B). Six of the membrane proteins are putative
components of as yet uncharacterized ABC transport systems, and
one is predicted to be an amino acid efflux protein. In addition, we
found MecA (SAUSA300_0032) on the surface of USA300 strain
LAC (Fig. 3B). MecA is the penicillin-binding protein that confers
resistance to b-lactam antibiotics in MRSA strains. We also
identified CapA (SAUSA300_2598), which is encoded by the first
gene in the staphylococcal capsule operon (Table S1). S. aureus
capsule operon expression is tightly regulated by agr and is usually
not present during the exponential phase of growth [19]. These
findings indicate that the proteomic approach utilized here was
sufficient to identify surface-exposed peptides from membrane
proteins.
Cytoplasmic proteins
Based on the number of proteins identified by surfome analysis,
the majority are putative or proven cytoplasmic proteins (Table
S1). However, as mentioned above, these proteins were signifi-
cantly less abundant on the surface than were those predicted to be
cell wall-associated and/or extracellular (Fig. 2B and Tables S1
and S2). Ribosomal proteins comprise 25 of the 63 (40%)
cytoplasmic proteins identified by our analysis, presumably as a
result of normal cell turnover. Although there was no decrease in
CFU/ml following digestion of surface proteins with trypsin, it is
likely that some cell lysis occurred during digestion or subsequent
processing, perhaps accounting in part for presence of cytoplasmic
proteins in our cell surface proteome analysis.
LukGH is a novel S. aureus leukotoxin
Using the combined Mascot score as a measure of relative
abundance, the 2
nd and 7
th most abundant USA300 proteins
identified by surface proteomics were LukH and LukG, respec-
tively (Table S1). As noted above, lukG and lukH are present in all
sequenced S. aureus strains and there is limited allelic variation
among the strains (97–100% nucleotide identity) (Fig. S2A).
USA300 strains contain up to 4 operons encoding known or
predicted two-component leukotoxins [20]. LukGH shares
significant homology with other staphylococcal leukotoxins,
including PVL and HlgABC (see figure 1 in ref. [21]) (Fig. S2C).
LukG is 37% identical to HlgB and 36% identical to LukF-PV,
and LukH is 26–28% identical to LukS-PV, HlgA and HlgC,
based on a CLUSTALW2 analysis of inferred amino acids from
strain FPR3757 (Fig. S2C). However, LukGH has not been
previously characterized and its function remains to be deter-
mined. Based on homology and predicted function as a secreted
toxin, LukGH should be secreted into the extracellular milieu
during post-exponential growth of S. aureus in vitro [10]. However,
Luong et al. describe expression of lukG (N315–1812) and lukH
(N315–1813) during late-exponential phase of growth [22].
Further, we demonstrated previously that lukH was highly
expressed during PMN phagocytosis (labeled as aerolysin/
leukocidin family protein or lukM in those reports), and following
exposure to neutrophil azurophilic granule proteins [5,23,24].
Figure 2. Relative abundance of proteins identified on the
surface of USA300. PSORT v2.0 was used to assign identified proteins
to subcellular compartments. (A) Total number of peptides assigned to
proteins in each cellular compartment. A total of 2559 peptides were
matched to proteins in the RSUE database. (B) Each data point in the
scatter plot represents one protein. The line for each cellular location
represents the median Mascot score for that compartment. Mascot
scores were evaluated by a Kruskal-Wallis test with Dunn’s post-test to
compare the relative confidence of protein identifications between
subcellular compartments.
doi:10.1371/journal.pone.0011634.g002
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constructed isogenic lukGH (DlukGH) and lukGH/lukSF-PV
(DlukGH/Dpvl) deletion mutants in USA300 (LAC) using the
counterselectable marker system developed by Bae and Schnee-
wind (Fig. 4A) [25]. We generated the USA300DlukGH/Dpvl strain
in the genetic background of a previously described USA300Dpvl
strain [23]. PCR analysis of genomic DNA isolated from the wild-
type and mutant strains confirmed lukGH were deleted from
DlukGH and DlukGH/Dpvl, and all strains exhibited virtually
identical growth in TSB media (Fig. 4B and C). Since LukGH has
identity to other two-component leukotoxins that are normally
secreted into culture media, we assessed exoprotein profiles of each
strain cultured to early-stationary phase of growth in CCY
medium, which promotes high production of PVL (Fig. 4D).
Protein bands corresponding to LukF-PV and LukS-PV (yellow
arrows) were clearly present in the media in which LAC wild-type
and DlukGH strains were cultivated, and absent in the media from
the Dpvl and DlukGH/Dpvl cultures (Fig. 4D). Similarly, bands
corresponding to LukG and LukH, as indicated by black arrows,
were present in the LAC wild-type and Dpvl supernatants, and
absent from supernatants derived from DlukGH and DlukGH/Dpvl
cultures (Fig. 4D). Rabbit IgG specific for LukG identified the
protein in culture supernatants, indicating the leukotoxin is at least
in part secreted (Fig. 4E). DlukGH and DlukGH/Dpvl were
complemented with lukGH encoded on a plasmid (DlukGH::plukGH
and DlukGH/Dpvl::plukGH, respectively), thereby restoring pro-
duction of the leukotoxin (as assessed by immunoblot for LukG)
(Fig. 4E). All strains produced equivalent amounts of alpha-
hemolysin or protein A, and had comparable levels of beta-
hemolysis on blood agar (data not shown), suggesting that the
global regulator agr remained intact during strain passage and
mutagenesis.
LukGH has cytolytic activity toward human PMNs
Because we detected LukGH in the culture media, we
compared the ability of CCY culture supernatants from LAC
wild-type, Dpvl, DlukGH, and DlukGH/Dpvl strains to cause
formation of plasma membrane pores in human PMNs (Fig. 5A).
Culture supernatants from Dpvl, DlukGH or DlukGH/Dpvl strains
had significantly decreased capacity to cause formation of
membrane pores compared with those from the wild-type strain
(Fig. 5A). Using conditions in which pore-forming capacity is
retained in either of the single operon deletion strains (30 min
incubation using more concentrated supernatants), culture super-
natants from the DlukGH/Dpvl strain typically caused little or no
formation of membrane pores (Fig. 5A). Complementation of the
DlukGH/Dpvl strain with a plasmid containing lukGH restored a
significant level of pore-forming capacity, thereby demonstrating
that LukGH contributes to neutrophil plasma membrane pore-
formation (Fig. 5A, far right panel).
Although we observed significantly reduced pore formation in
PMNs exposed to the highest concentration of culture superna-
tants from Dpvl or DlukGH strains (1:250 dilution at 5 or 15 min)
(Fig. 5A), there was only a limited corresponding decrease in PMN
lysis (as measured by LDH release) (Fig. 5B). For example,
supernatants from cultures of Dpvl or DlukGH strains retained most
Figure 3. Membrane association of LukG and predicted topology for putative membrane proteins. (A) Immunoblot analysis of LukG
secreted into the culture media (extracellular) or associated with subcellular fractions of USA300. Subcellular fractions were prepared as described in
Materials and Methods. (B) Predicted membrane proteins identified by surface proteomics. Blue regions indicate areas of peptide coverage.
doi:10.1371/journal.pone.0011634.g003
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PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11634Figure 4. Construction and characterization of isogenic USA300 lukGH deletion (DlukGH) strains. (A) Schematic of deletion strategy for
generation of DlukGH and (B) confirmation of isogenic DlukGH and DlukGH/Dpvl strains by PCR as described in Methods. (C) Growth of LAC wild-type,
DlukGH and DlukGH/Dpvl strains. (D) Exoprotein profile of LAC culture supernatants from early-stationary phase of growth (6 h). Proteins were
resolved by SDS-PAGE and stained with Sypro Ruby. Black arrows correspond to LukG and LukH and yellow arrows denote LukF-PV and LukS-PV. (E)
Immunoblot analysis of LukG and LukF-PV from culture supernatants of LAC wild-type-, isogenic gene deletion-, and complemented gene deletion
strains as indicated.
doi:10.1371/journal.pone.0011634.g004
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PMNs—although there was a trend for decreased LDH release
(Fig. 5B). This finding is consistent with our studies indicating that
PMN pore formation does not necessarily correlate with cytolysis
[26]. By contrast, culture supernatants from the DlukGH/Dpvl
strain had zero cytolytic capacity, indicating synergy or coopera-
tivity between PVL and LukGH (Fig. 5B). We note that culture
supernatants from the Dpvl strain had significantly reduced
cytolytic capacity by 6 h (LDH release was 58.067.9% for wild-
type supernatants and 33.865.4% for those from the Dpvl strain,
P,0.05), but the differential supernatant lysis between the two
mutant strains is likely due to the selective overproduction of PVL
in CCY media (Fig. 4D) [26,27]. The finding that there is synergy
between PVL and LukGH merits further investigation.
Inasmuch as we identified LukGH by surface proteome analysis,
we tested the hypothesis that surface-associated LukGH contrib-
utes to rapid lysis of human PMNs after phagocytosis of USA300
[5]. Lysis of PMNs 6 h after phagocytosis of the Dpvl strain was
comparable to that caused by the wild-type USA300 strain (LDH
release was 63.2612.0% and 59.3617.0% for the wild-type and
Dpvl strains, n=10) (Fig. 5C). These findings are consistent with
our previous studies demonstrating PVL does not contribute to
lysis of PMNs after phagocytosis [5,23]. By comparison, DlukGH or
DlukGH/Dpvl strains had significantly reduced capacity to cause
lysis after uptake by PMNs (e.g., LDH release was 35.5615.9%
following phagocytosis of DlukGH, P,0.01 versus LAC wild-type)
(Fig. 5C). The complemented mutant strains, DlukGH::plukGH and
DlukGH/Dpvl::plukGH, caused PMN lysis at a level similar to that
of the wild-type strain (Fig. 5C). Although it was not possible to
differentiate the relative contribution of surface-associated versus
freely secreted LukGH in this process, there is a relative high
abundance of surface-associated LukGH, whereas the other two-
Figure 5. LukGH contributes to PMN plasma membrane pore formation and lysis. (A) Permeability of human PMNs exposed to culture
supernatants from LAC wild-type-, isogenic gene deletion-, or complemented gene deletion strains. (B) Capacity of LAC wild-type and mutant CCY
culture supernatants to cause PMN lysis. Dilution of culture supernatants was 1:250. (C) PMNs were cultured with LAC strains for 6 h and PMN lysis
was determined by release of LDH. Statistical analyses for panels (A, B, and C) were performed using repeated-measures ANOVA or one-way ANOVA
and Tukey’s posttest. *P,0.05 versus LAC or {P,0.05 as indicated. Results are the mean 6 standard deviation of 4 (panel A), 3 (panel B) or 4–10
(panel C) PMN donors.
doi:10.1371/journal.pone.0011634.g005
Novel S. aureus Leukotoxin GH
PLoS ONE | www.plosone.org 6 July 2010 | Volume 5 | Issue 7 | e11634component leukotoxins are either not present on the cell surface
(LukS-PV, LukF-PV, LukD, LukE, HlgB, HlgC) or are present in
much lower abundance (i.e., HlgA) (Table S1). Taken together,
these data demonstrate that LukGH has potent cytolytic activity
toward human neutrophils.
Concluding remarks
Rodriguez-Ortega et al. used a surface proteomics approach to
identify proteins present on the surface of group A Streptococcus,s o m e
of which are potential vaccine candidates [9]. More recently, Solis et
al. evaluated the surface proteome of S. aureus strain COL using
methodology that reduces contamination with proteins from the
cytoplasm [28]. Indeed, we recovered a higher percentage of peptides
corresponding to cytoplasmic proteins than did Solis et al., but
Mascot scores for the corresponding cytoplasmic proteins were
significantly lower than those of cell-wall associated, extracellular, or
membrane proteins (Fig. 2B). Many of the proteins identified here by
our surface proteome analysis, such as Atl, ClfB, MecA, IsaA, IsdH,
SasF, and Spa, were also reported to be surface-associated by Solis et
al. [28]. However, to our knowledge, LukG and LukH have not been
identified previously as exoproteins.
S. aureus has the capacity to produce several homologous two-
component leukotoxins, including gamma-hemolysin (Hlg, encoded
by hlgA, hlgB, and hlgC) [29,30], leukotoxin D and E (LukDE, encoded
by lukD and lukE) [31], LukM and LukF’-PV [32], and PVL (encoded
by lukS-PVand lukF-PV within specific bacteriophage) [33–39]. These
toxins assemble as pore-forming multimers on the surface of
susceptible target cells, such as neutrophils, monocytes, and
macrophages, and can thereby alter host cell function or cause
cytolysis [40–43]. Genes encoding Hlg and LukDE are present in the
vast majority of sequenced S. aureus strains or clinical isolates tested
[44], whereas those encoding PVL exist in 5% or less of all clinical
isolates [44–46]. lukMand lukF’-PV are associated withS. aureus strains
that cause mastitis in cows, ewes, and goats, but have not been found
in human clinical isolates [44]. In addition, all sequenced S. aureus
strainscontainopenreadingframes(ORFs)encodingapotentialtwo-
component leukocidin that has remained uncharacterized. The lukF
subunit of this potential leukotoxin (ORF SAUSA300_1974 in
USA300 strain FPR3757) is annotated as a leukocidin/hemolysin
toxin family protein with 38–39% identity to LukD, HlgB, HlgC, and
LukF-PV. The lukS subunit (SAUSA300_1975 in FPR3757) is
annotated as an aerolysin/leukocidin family protein with 35%
identity to LukM and 31% identity to LukS-PV. We have previously
shown that this gene is up-regulated in strain MW2 (USA400) during
phagocytic interaction with human neutrophils (called lukM in that
study) [23].
Herein we used a surface proteomics approach to identify this
previously uncharacterized leukotoxin (LukGH) as an abundant
exoprotein of USA300. LukGH was both surface-associated and
present in USA300 culture media. Using isogenic USA300 mutants,
we discovered that this novel leukotoxin has potent cytolytic activity
toward neutrophils and can work synergistically with PVL to cause
PMN lysis. Given the high abundance of LukGH in our surface
proteinpreparations,and the criticalrolethat neutrophilsplayinhost
defense against S. aureus infection, it is tempting to speculate that the
toxin contributes to the enhanced virulence phenotype of USA300.
Studies in animal infection models to demonstrate a role for LukGH
in S. aureus virulence are ongoing.
Materials and Methods
Ethics statement
Human neutrophils were isolated from heparinized venous
blood of healthy donors in accordance with a protocol approved
by the NIAID Institutional Review Board for human subjects.
Donors were informed of the procedure risks and provided written
consent prior to enrollment.
Bacterial strains and culture conditions
We used USA300 strain LAC (Los Angeles County clone) for
surfome analysis. LAC has been described and characterized
previously [5] and is representative of the USA300 epidemic clone
[47]. LAC was grown in trypticase soy broth (TSB) or CCY media
(3% yeast extract, 2% Bacto-casamino acids, 0.21 M sodium
pyruvate, 44 mM dibasic sodium phosphate, 3 mM monobasic
potassium phosphate, pH 6.7) in a flask-to-media volume ratio of
5:1 at 225 rpm at 37uC. LAC was cultured overnight in TSB,
diluted 1/200 into fresh media, and subcultured in either TSB or
CCY using the same conditions until the desired growth phase was
obtained (late-exponential phase in TSB for proteomics, early-
stationary phase in CCY for culture supernatant assays with
PMNs, and mid-exponential phase in TSB for PMN lysis assays
with intact bacteria). Growth curve analysis in TSB was performed
in triplicate for each strain, and bacteria were plated for
enumeration on trypticase soy agar plates.
Sample preparation for proteomics analysis
USA300/LAC was cultured in TSB to late-exponential phase of
growth (OD600=0.8521.0) in 25- or 100-ml volumes. Bacteria
were harvested by centrifugation at 4,000 g for 15 min at 4uC, and
washed 3 times with a volume of chilled 50 mM Tris, pH 7.5, that
was equivalent to the original culture volume. The pellet was
resuspended in 1 ml (25 ml culture) or 3 ml (100 ml culture) of
chilled 50 mM Tris, pH 7.5, and aliquoted (1 ml/tube) into 1.5-
ml Protein Lo-Bind tubes (Eppendorf North America, Westbury,
NY). Bacteria were pelleted at 16,100 g for 5 min at 4uC and
resuspended in 0.3 ml digestion buffer (0.6 M sucrose buffered
with 50 mM Tris, pH 7.5,) containing 2 mM dithiothreitol
(DTT), and 10–12 mg mass spectrometry-grade trypsin (Promega,
Madison, WI). Sucrose was included in the digestion buffer to
facilitate swelling of the bacterial cells, which enhances trypsin
digestion of surface proteins [9]. Bacteria were digested with
trypsin for 1 h at 37uC. A 256 solution of SIGMAFast protease
inhibitor cocktail (Sigma-Aldrich Company, St. Louis, MO) was
prepared in digestion buffer; the cocktail was added to a final
concentration of 16following trypsin digestion. An aliquot of the
digested sample before and after incubation at 37uC was diluted
serially in 50 mM Tris, pH 7.5, and plated on trypticase soy agar
plates to assess bacterial viability. Following trypsin digestion,
bacteria were pelleted by centrifugation at 8,000 g for 10 min at
4uC. The supernatant containing tryptic peptides from USA300
surface proteins was clarified/sterilized by using a Microcon YM-
100 centrifugal filter unit (Millipore, Billerica, MA) at 4uC for
25 min. The filtrate was frozen at 280uC until further processing.
Fractionation of tryptic peptides
Several approaches were used to prepare enriched peptide
fractions. Trifluoroacetic acid (TFA) was added to the tryptic
peptides from three 25-ml cultures to a final concentration of 0.2%
and extracted using a reverse phase polymer peptide trap cartridge
(Michrom Bioresources, Auburn, CA) to remove interfering salts
and sucrose. The dried sample was dissolved in 50 mlo f5 0m M
formic acid/75% isopropanol and applied to polyhydroxyethyl A
10-ml solid phase extraction tip (Glygen Corporation, Columbia,
MD). The analytes were eluted with 10 ml of 15 mM ammonium
acetate, pH 3.5/3% acetonitrile, 0.1% TFA and fractionated by
reverse phase chromatography using a Zorbax XDB 5 mm C18,
0.5 mm 6150 mm column on an 1100 series capillary HPLC
Novel S. aureus Leukotoxin GH
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were run from 0.1% TFA/3% acetonitrile to 60% acetonitrile.
Column effluent was monitored at 220 and 280 nm. The 12-ml
column fractions were dried and dissolved in 4.5 ml of 0.1% acetic
acid/50% methanol for analysis by mass spectrometry. In other
experiments, the tryptic peptides from five 25-ml cultures were
adjusted to pH 2.8 by the addition of 10% formic acid and applied
to a Polysulfoethyl A 10-ml solid phase extraction tip (Glygen
Corporation). Following a 100-ml wash with 0.2% formic acid/5%
acetonitrile, the resin was eluted with 20 ml of 0.01, 0.05, 0.1, 0.5
and 1 M NaCl in the same solvent. The batches were dried,
dissolved in 10 ml of 0.1% TFA/3% acetonitrile and each
submitted to reverse phase chromatography as described. Ion
exchange chromatography was also performed with a Zorbax
SCX, 5 mm 2.1 mm 650 mm column on a 1100 series analytical
HPLC system (Agilent Technologies) using the peptides from
eleven 25-ml cultures. The column was developed with a gradient
of NaCl from 0.01 to 1 M in 0.2% formic acid/5% acetonitrile.
The 0.2-ml fractions were combined into seven separate pools
which were qualitatively based on the UV peak patterns at
220 nm. After drying under vacuum 5 of the 7 pools were
dissolved in 10 ml of 0.1% TFA/3% acetonitrile and submitted to
reverse phase chromatography. The two higher salt pools were
dissolved in 200 ml 0.1% TFA and desalted by reverse phase
cartridge as described prior to capillary HPLC.
Protein identification by mass spectrometry
Protein identification, for 1D and/or 2D LC resolved peptides,
was performed on reduced and alkylated, trypsin-digested S. aureus
prepared as described above. HPLC recovered peptide pools were
injected by direct infusion with a Nanomate (Advion BioSciences,
Ithaca, NY), an automated chip-based nano-electrospray interface
source coupled to a quadrupole–time of flight mass spectrometer,
QStarXL MS/MS System (Applied Biosystems/Sciex, Framing-
ham, MA). Computer-controlled data-dependent automated
switching to MS/MS provided peptide sequence information.
AnalystQS software (Applied Biosystems/Sciex) was used for data
acquisition. Data processing and databank searching were
performed with Mascot software (Matrix Science, Beachwood,
OH) and a database containing forward and decoy sequences
(RSUE database) that was constructed using the
USA300_FPR3757 sequence.
Identification of proteins. Bioinformatics analysis was carried
out using the following online resources (reported in Table S1).
Genome sequence; USA300_FPR3757 (NCBI accession
#CP000255). Protein parameters (molecular mass, isoelectric point,
GRAVY index); ProtParam tool, http://ca.expasy.org/tools/
protparam.html [48]. Localization of proteins; PSORTb v.2.0,
http://www.psort.org/ [11]. Membrane topology; HMMTOP,
http://www.enzim.hu/hmmtop/ [49]. Signal sequence prediction;
SignalP 3.0, http://www.cbs.dtu.dk/services/SignalP/ [50]; PrediSi,
http://www.predisi.de/.Anchoring domain prediction; AUGUR,
http://www.bioinfo.mikrobio.med.uni-giessen.de/augur/[51].Ami-
no acid alignment; CLUSTALW2, http://www.ebi.ac.uk/Tools/
clustalw2/index.html [52].
Construction of isogenic lukGH deletion mutants
(DlukGH)
Isogenic lukGH (SAUSA300_1974 and SAUSA300_1975 in
USA300 strain FPR3757, NCBI accession #CP000255) deletion
mutants (DlukGH) were generated in LAC wild-type and LACDpvl
strains [23] using a previously described allelic replacement
method [25]. Briefly, the 39 region of the allelic replacement
cassette was generated by PCR amplification of LAC genomic
DNA with the primers 1973attB1-F and 1974SphI-R, and the 59
region with 1975SphI-F and 1976attB2-R. PCR products were
purified, digested with SphI, ligated, and transferred into plasmid
pKOR1 by recombination [25]. The resulting plasmid construct
(pKOR1-DlukGH) was used for allelic replacement as described










Deletion of lukGH was confirmed in DlukGH and DlukGH/Dpvl
strains by PCR using primers 1973attB1-F and 1976attB2-R. PCR
confirmation that Dpvl was maintained during mutagenesis was
carried out as previously described [23].
To generate the complemented gene deletion strains, DNA
encoding the ribosome binding site and lukGH ORF were PCR-
amplified from the USA300 genome and ligated into BamHI and
NarI sites of the S. aureus expression vector pTX-15 [53]. The
resulting plasmid (plukGH) was transformed into DlukGH and
DlukGH/Dpvl to produce DlukGH::plukGH and DlukGH/
Dpvl::plukGH. Primers used to construct the lukGH complementa-





LukGH expression was confirmed by SDS-PAGE and immu-
noblot analysis as described below.
SDS-PAGE and immunoblotting
LAC wild-type and isogenic Dpvl, DlukGH, and DlukGH/Dpvl
deletion strains were cultured to early-stationary phase of growth
in CCY media (OD600=2.0). Bacteria from 10 ml of culture were
pelleted by centrifugation. Culture supernatant was aspirated,
filter-sterilized, and stored at 280uC until use. Samples were
boiled in Laemmli sample buffer [54] for 5 min and separated by
12.5% SDS-PAGE using Criterion precast polyacrylamide gels
(Bio-Rad, Hercules, CA). Proteins were transferred to PVDF
membranes using the iBlot transfer system (Invitrogen, Carlsbad,
CA). Membranes were blocked using 10% goat serum in Tris-
buffered saline containing 0.05% Tween-20 and antibody
incubations were performed in blocking buffer diluted 1:4 in
TBS. Washes were performed in triplicate for 15 min each
between antibody incubations using wash buffer (250 mM NaCl,
10 mM Hepes, and 0.2% Tween-20). LukG was detected using
affinity-purified rabbit IgG directed against a peptide region of the
protein (LWAKDNFTPKDKMP) (GenScript Corporation, Pis-
cataway, NJ) and a donkey anti-rabbit IgG-HRP secondary
antibody (Jackson ImmunoResearch, West Grove, PA). PVL was
detected as described previously [26]. Proteins were visualized
using a Supersignal West Pico Horseradish Peroxidase Detection
Kit (Pierce Biotechnology, Rockford, IL) and X-ray film (Phenix
Research Products, Chandler, NC).
Subcellular localization of LukG
Bacteria from early-stationary phase (8 h) cultures were
harvested by centrifugation (8,0006 g for 10 min), washed with
deionized water, and disrupted by high pressure (18,000 psi) using
a French Press. The cell lysate was treated with Protease Inhibitor
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away, NJ) and the particulate fraction, which includes cell
envelope components, was isolated by centrifugation (25,0006 g
for 30 min at 4uC). The clarified lysates, which contain
cytoplasmic proteins, were stored at 280uC until used. The
resulting pellet, containing cell envelope components, was
resuspended in rehydration buffer (7 M urea, 2 M thiolurea, 2%
triton X-100, 2 mM tributylphosphine, and 1% bromophenol
blue) and incubated at ambient temperature for 2 h. These
samples were clarified by centrifugation (25,0006g, 30 min) and
proteins were analyzed by SDS-PAGE and immunoblotting
(labeled as ‘‘membrane fraction’’ in Fig. 3A). Detergent-insoluble
material (pellet from above) was incubated for 3 h in TE buffer
(50 mM Tris-HCl and 10 mM EDTA, pH 8.0) with lysostaphin
(40 mg/ml). These samples were clarified by centrifugation
(25,0006g, 30 min) and soluble material was analyzed by SDS-
PAGE (labeled as ‘‘lysostaphin extract’’ in Fig. 3A).
Culture supernatant proteins were precipitated with 9 vol of
trichloroacetic acid:acetone (1:8 v/v for 2 h at 220uC) and then
analyzed by SDS-PAGE and immunoblotting as described above
(labeled as ‘‘extracellular proteins’’ in Fig. 3A).
Human PMN assays
Human neutrophils were isolated from heparinized venous
blood of healthy donors using a published method [55]. PMN
plasma membrane permeability (pore formation) was assessed by
ethidium bromide (EtBr) uptake as described previously [23,26].
Neutrophil lysis either after incubation with CCY culture
supernatant or following phagocytosis of serum opsonized
USA300 was measured by the release of lactate dehydrogenase
(LDH) using a Cytotoxicity Detection Kit (Roche Applied
Sciences, Pleasanton, California) as described previously [23,26].
Statistical analyses
All statistical analyses were performed using GraphPad Prism.
Comparison of Mascot score distribution across subcellular
components was performed using the Kruskal-Wallis test with
Dunn’s post-test. One-way or repeated-measures ANOVA
followed by Tukey’s post-test was used to assess significance in
PMN pore formation and lysis assays.
Supporting Information
Figure S1 USA300/LAC remains viable following trypsin
digestion of surface proteins. (A) Bacteria were grown to the
late-exponential phase of growth, harvested, washed, and
resuspended in 0.6M sucrose and 2 mM DTT to promote
exposure of surface proteins. Following addition of trypsin,
colony-forming units were enumerated immediately (0 min) or
after 60 min of incubation as described in methods. (B) Sypro
Ruby-stained Tricine SDS-PAGE shows the low molecular weight
tryptic peptides. The dominant bands at ,15 kDa and ,20 kDa
represent singly autodigested trypsin and full-length trypsin,
respectively.
Found at: doi:10.1371/journal.pone.0011634.s001 (0.11 MB TIF)
Figure S2 Presence of LukG and LukH among S. aureus strains
with published genomes and homology with other two-component
leukotoxins. (A) Comparison of the DNA sequences of lukG and
lukH with other sequenced S. aureus strains. (B) Inferred amino
acid homology of LukG and LukH among sequenced S. aureus
strains. (C) Homology of LukG and LukH with other S. aureus
two-component leukotoxins. Alignments were generated by
GeneDoc software v. 2.7. The nucleotide sequences for strains
USA300_TCH1516, Newman, NCTC 8325, USA300_FPR3757,
ED98, Mu3, JH1, JH9, N315, Mu50, RF122, MSSA476, MW2
and COL were obtained from NCBI database (GenBank accession
no. CP000730, AP009351, CP000253, CP000255, CP001781,
AP009324, CP000736, CP000703, BA000018, BA000017,
AJ938182, BX571857, BA000033, CP000046, respectively). A
gap, indicated by a bar, was introduced by the program
CLUSTALW2 (www.ebi.ac.uk/Tools/clustalw2/index.html) to
obtain maximal alignment of amino acids. Black shading indicates
identical amino acids.
Found at: doi:10.1371/journal.pone.0011634.s002 (0.25 MB
DOC)
Table S1 USA300 proteins identified by surface proteomics. a)
Cellular localization of protein as determined using PSORT v2.0. b)
FPR3757 number corresponds to the gene number in the published
FPR3757 genome [27]. c) Signal sequences were identified using the
Gram-positive signal sequence prediction function on the SignalP 3.0
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Table S2 The surface proteome (surfome) of USA300 strain
LAC contains cell wall-associated, extracellular, membrane, and
cytoplasmic proteins. A total of 113 proteins were identified in the
LAC surfome. The peptide abundance ranking in Column A was
determined by ranking the identified proteins by 1) Combined
Mascot Score (Column G), then 2) Queries matched (Column E),
then 3) Unique peptides matched (Column F). The FPR3757
number in Column C refers to the gene number in the
SAUSA300_FPR3757 genome. The Percent Coverage (Column
H) was determined by dividing the number of peptides identified
by the total number of tryptic peptides in a given protein. SignalP
3.0 and PrediSi were used to determine if a Gram-positive signal
sequence was present in each identified protein (Columns I and J).
The GRAVY index (Column M) is a measure of the hydropho-
bicity of each identified protein. The PSORT localization
(Column N) was assigned based upon the PSORT 2.0 localization
for FPR3757. The experimental/knowledge localization (Column
O) was assigned based upon 1) published data that demonstrate
localization of the protein, or 2) PSORT 2.0 data if published data
were not available. Whether a protein contained an anchoring
domain was determined using AUGUR. The cell wall anchoring
domain (Column P) was then identified by visual inspection of the
primary protein sequence. The signal peptide cleavage site
(Column Q) was identified using SignalP-NN.
Found at: doi:10.1371/journal.pone.0011634.s004 (0.06 MB
XLS)
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